Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

JTCR 016

Next Previous
X
Search
Drug Profile

JTCR 016

Alternative Names: High-affinity WT1-specific TCR T cells - Juno Therapeutics; HLA-A2/WT1-specific TCR T cells - Juno Therapeutics; JTCR016; WT1 TCR-transduced T-cell therapy - Juno Therapeutics; WT1-sensitised T cells - Juno Therapeutics

Latest Information Update: 02 Aug 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Juno Therapeutics
  • Developer Fred Hutchinson Cancer Research Center; Juno Therapeutics
  • Class Gene therapies; Immunotherapies; T lymphocyte cell therapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Chronic myeloid leukaemia; Mesothelioma; Myelodysplastic syndromes; Non-small cell lung cancer; Precursor cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 02 Aug 2019 Phase I/II development is ongoing in USA
  • 06 Mar 2018 Juno Therapeutics has been acquired by Celgene Corporation
  • 22 Mar 2017 Juno Therapeutics plans a third phase I/II trial for Acute myeloid leukaemia in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top